Omega Fund Management »

Odyssey Therapeutics shares owned by Omega Fund Management

Quarter-by-quarter ownership of Odyssey Therapeutics shares owned by Omega Fund Management from 13F filings

Historical chart of Omega Fund Management investment in Odyssey Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Odyssey Therapeutics held by Omega Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Odyssey Therapeutics by Omega Fund Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $54k 2.9k 18.71

More positions owned by Omega Fund Management

Bicara Therapeutics Common Stock (BCAX)
Nuvation Bio Common Stock Class A (NUVB)
Kestra Med Technologies Common Stock (KMTS)
BridgeBio Oncology Therapeutics Common Stock (BBOT)
Beta Bionics Common Stock (BBNX)
Alumis Common Stock (ALMS)
Sana Biotechnology Common Stock (SANA)
ImageneBio Common Stock (IMA)
enGene Holdings Common Stock
Odyssey Therapeutics Common Stock

View all positions for Omega Fund Management

Top funds holding Odyssey Therapeutics

FMR
Sr One Capital Management
Tpg Gp A
Lightspeed Management Company
OrbiMed Advisors
Sanofi
Deerfield Management Company
Sands Capital Ventures
Hillhouse Capital Advisors
General Catalyst Group Management
Affinity Asset Advisors
Adage Capital Partners GP
Vanguard Capital Management
Foresite Capital Management V
Vivo Capital

View all funds holding Odyssey Therapeutics